ArticleInvestigative ophthalmology & visual science2025
Spatial Proteomic Analysis Highlights Molecular Reprogramming in Optic Nerve Invasive Retinoblastoma.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Molecular reprogramming at the interface between malignant and non-malignant contributes to heterogeneity and metastasis across various cancers. The optic nerve metastasis serves as a significant prognostic indicator for mortality in retinoblastoma (RB). This study seeks to unveil the molecular underpinnings of this phenomenon. Methods: We conducted a spatial proteomic analysis to delineate the heterogeneity within three RB samples exhibiting optic nerve invasion (ONI): case 1 and case 2 comparing the optic nerve invasive (ONI) group and the intraretinal group, and case 3 comparing tumor boundary and center. Data were archived in Mendeley Data [V1] (doi: 10.17632/xvtw7gmhzx.1; doi: 10.17632/mbsh6pcsnc.1). Immunofluorescence was performed to validate the expression patterns in additional RB samples of ONI versus the intraretinal group (n = 3 for each), and tumor boundary and center of neural metastasis (n = 4 for each). Results: Spatial proteomic analysis identified significant alterations in cholesterol metabolism in optic nerve-invasive lesions compared with intraretinal lesions. The boundary of the invasive RB at the optic nerve demonstrated an upregulation of anaplerotic reaction and oxidative respiration, along with a significant enhancement of keratin-mediated cytoskeletal remodeling. Moreover, the boundary lesions exhibit epigenetic remodeling, following decreased lysine methyltransferase 5C (KMT5C) levels, an important regulator of the epithelial/mesenchymal transition. Consistently, immunofluorescence analysis of pyruvate carboxylase (PC), keratin 17 (KRT17), and KMT5C substantiated distinct expression patterns in tumor boundary and center lesions. Conclusions: This study initially presents the spatial proteomic heterogeneity landscape in RB with ONI and uncovers its molecular reprogramming.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.